RxDoctor Payments Data

Paul Pearson, MD

Retina Specialist · Lexington, KYNPI 1992745871

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 60.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $491 and has fallen 54.2% since, to $225 in 2024. That places this record below the midpoint for retina specialist clinicians in KY, where the typical reported total is $4,563.

$1,784in general payments, 2019–2025

Across 22 payments — averaging $81.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$1K
  • Genentech USA, Inc.$247
  • Genentech, Inc.$192
  • Johnson & Johnson Surgical Vision, Inc.$142
  • Novartis$89
  • Covidien LP$21
  • plus $19 from 1 others

What the payments were for

  • Food & beverage$1,76599%
  • Gifts$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,784 in reported general payments places this provider in the 40th percentile of 22 retina specialist providers in Kentucky.

See all retina specialist providers in Kentucky

Medicare billing

Part B allowed, 2024
$431,969
Medicare patients
403
Services billed
5,758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Difluprednate22$1,228
Prednisolone Acetate20$587
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat22$556
Brimonidine Tartrate11$224
Latanoprost18$156
Timolol Maleate13$121

Paid to pharmacies, not to this prescriber.

Other retina specialist in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →